WebJan 6, 2024 · Glaukos Corporation (NYSE:GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today ... WebAccessGUDID - iPRIME (00853704002456)- Viscodelivery System. Brand Name: iPRIME Version or Model: VCP100 Commercial Distribution Status: In Commercial Distribution …
Glaukos Corporation Receives 510(K) Clearance from the U.S.
WebJan 11, 2024 · iPrime is a sterile, single-use, minimally invasive product designed to deliver viscoelastic fluid during eye surgeries. A pioneer in minimally invasive glaucoma surgery, … WebJun 1, 2024 · June 1, 2024 Glaukos Corporation received FDA 510 (k) clearance for its Iprime viscodelivery system, a sterile, single-use, minimally invasive device for the delivery of viscoelastic fluid during ophthalmic surgery. lutheran church oconomowoc
QUICK HITS - Ophthalmology Management
WebJan 6, 2024 · Glaukos Corporation (NYSE: GKOS), today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iPRIME™ … WebJan 7, 2024 · James Hardie Industries plc (NYSE:JHX) named Harold Wiens as interim CEO. PriceSmart, Inc. (NASDAQ:PSMT) reported better-than-expected results for its first quarter on Thursday. Glaukos Corporation... WebJan 14, 2024 · Alcon plans to pursue standalone surgery indications for Hydrus Microstent in the United States with clinical trials underway. Glaukos Corp. received 510 (k) clearance from the FDA for the iPRIME Viscodelivery System, a sterile, single-use, minimally invasive device for the delivery of viscoelastic fluid during ophthalmic surgery. jcccgboot